The Cox regression model predicts recurrence risk in early endometrial cancer, suggesting improved treatment planning.
The developed nomogram provides a reliable and effective tool for individualized recurrence risk assessment in early-stage endometrial cancer, demonstrating significant clinical potential for improved risk prediction and treatment planning.
No takes yet. Share an insight, caveat, or question.
Hao et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: